This Plain Language Summary of Publication from Future Oncology describes the new set of recommendations made by the European Society for Medical Oncology (ESMO) which cover the management of people with a type of lung cancer called epidermal growth factor receptor-positive non-small-cell lung cancer (EGFR-positive NSCLC).
Read the full article here.
The original article on which this Plain Language Summary of Publication is based is titled ‘ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer’ and was published in Annals of Oncology. Read the original article here.